Peptide Schedule
SNAP-89 residuesEEEMQRRADEach bubble = one amino acid. Size = residue mass. Color = chemical class.

SNAP-8

Anti-AgingTopicalResearchGrade BUnknown (topical peptide — no systemic PK data) half-life
Anti-WrinkleTopical PeptideCosmeceutical12 weeks on / 2 weeks off

Benefits

Reduces expression line depth by modulating muscle contraction
Non-invasive topical alternative to botulinum toxin injections
Approximately 30% more potent than Argireline in comparative studies
Preserves natural facial expression while softening wrinkles
Stimulates collagen-supporting skin environment when used consistently
Well-tolerated with minimal side effects in topical form
Can be combined with other anti-aging peptides like GHK-Cu
Half-Life
Unknown
Route
Topical
Frequency
Daily
Vial Sizes
5mg, 10mg
BAC Water
Pre-filled
Safety Grade
Grade B
Open SNAP-8 Dosage Calculator
Calculate exact syringe units for your vial and dose

About SNAP-8

SNAP-8 (Acetyl Octapeptide-3) is an eight-amino-acid peptide designed to reduce the appearance of expression lines and wrinkles through a mechanism similar to botulinum toxin — but without injections. Its sequence (Ac-Glu-Glu-Met-Gln-Arg-Arg-Ala-Asp-NH2) mimics the N-terminal end of SNAP-25, a protein that forms part of the SNARE complex responsible for neurotransmitter release at neuromuscular junctions. By competing with native SNAP-25 for binding within the SNARE complex, SNAP-8 destabilizes vesicle fusion and reduces acetylcholine release, which in turn attenuates the muscle contractions that cause dynamic wrinkles. Unlike Botox, SNAP-8 does not cleave SNAP-25 or paralyze muscles — it modulates contraction intensity, allowing natural facial expressions while softening lines. In vitro studies show SNAP-8 inhibits glutamate release by up to 43% at 1.5 mM concentration, and in vivo human trials with 10% topical SNAP-8 cream reported an average wrinkle depth reduction of 35%, with some subjects reaching 63% reduction over 28 days. SNAP-8 is approximately 30% more active than its six-amino-acid parent peptide Argireline (Acetyl Hexapeptide-8) in comparative testing. The primary limitation is skin penetration: as a hydrophilic peptide, SNAP-8 struggles to cross the lipophilic stratum corneum efficiently. Advanced delivery systems such as multiple emulsions, liposomes, or microneedling can improve dermal absorption. SNAP-8 is considered a cosmeceutical ingredient and is not FDA-approved for any medical indication. It remains a research-only compound with a strong safety profile in topical applications but limited peer-reviewed clinical validation independent of manufacturer-funded studies.

Who Should Consider SNAP-8

  • Adults over 30 with early expression lines seeking non-invasive treatment
  • Individuals who want wrinkle reduction without botulinum toxin injections
  • Skincare enthusiasts looking for peptide-based anti-aging serums
  • Those with dynamic wrinkles on forehead, crow's feet, or glabella
  • People seeking to extend the interval between Botox appointments

How SNAP-8 Works

SNAP-8 mimics the N-terminal domain of SNAP-25 (Synaptosomal-Associated Protein of 25 kDa), one of three proteins that assemble into the SNARE complex. The SNARE complex is responsible for docking synaptic vesicles at the presynaptic membrane and triggering calcium-dependent exocytosis of acetylcholine into the neuromuscular junction. By competing with endogenous SNAP-25 for its position in the SNARE trimer, SNAP-8 partially destabilizes the complex, reducing vesicle fusion efficiency. This decreases acetylcholine release without fully blocking it, resulting in attenuated — not paralyzed — muscle contraction. The net effect is a relaxation of the facial muscles that create expression lines (forehead furrows, crow's feet, frown lines), producing a visible smoothing of dynamic wrinkles over repeated application.

What to Expect

Week 1

No visible changes expected. SNAP-8 begins accumulating in the upper skin layers. Some users notice a mild tightening or smoothing sensation after application.

Weeks 2-4

Early wrinkle softening may become apparent, especially on fine expression lines. Clinical studies show measurable wrinkle depth reduction beginning around week 2-3.

Weeks 4-8

Peak reduction in wrinkle depth — clinical trials report average reductions of 35% with some subjects reaching 63% at the 28-day mark.

Weeks 8-12

Continued maintenance of wrinkle reduction gains. Deeper expression lines may show further gradual improvement.

After stopping

Effects are not permanent. Wrinkle depth gradually returns to baseline over 4-8 weeks after discontinuation.

Dosing Protocol

LevelDose / InjectionFrequency
Beginner100mcgDaily
Moderate250mcgDaily
Aggressive500mcgDaily

Note: Topical anti-wrinkle peptide, also known as Acetyl Octapeptide-3. Typically applied in serum form at 3-10% concentration twice daily. The dosing tiers above reflect research-grade topical solution amounts per application in mcg. At 10% concentration, clinical studies report up to 63% wrinkle depth reduction over 28 days. Best applied to clean, dry skin on expression-line areas (forehead, crow's feet, glabella).

How to Inject SNAP-8

Apply a thin layer of SNAP-8 serum (3-10% concentration) to clean, dry skin on target areas — typically forehead lines, crow's feet, and glabellar frown lines. Use morning and evening before moisturizer. Allow 2-3 minutes for absorption before applying other products. For enhanced penetration, consider pairing with a derma roller (0.25-0.5mm) or using a formulation with penetration enhancers. Avoid applying to broken or irritated skin.

Cycling Protocol

On Period
12 weeks
Off Period
2 weeks

Apply twice daily for 12 weeks, then take a 2-week break. Wrinkle reduction is cumulative and peaks around week 4-8. Effects diminish gradually after stopping. No receptor desensitization has been reported, so extended continuous use is also practiced.

Pharmacokinetics

Half-Life
0min
Bioavailability
Topical: <1% systemic absorption; dermal penetration is the primary barrier
Tmax
Not applicable (topical, non-systemic)
Data Confidence
low

Source: No systemic pharmacokinetic data available. SNAP-8 is a topical cosmeceutical peptide; skin penetration studies show less than 1% reaches beyond the stratum corneum.

Pharmacokinetics — Active Dose Over Time

Loading the interactive decay curve.

Side Effects

Generally well-tolerated as a topical application. Mild temporary tingling or slight redness at the application site may occur. Rare reports of dryness or contact sensitization. No systemic side effects expected from topical use due to limited dermal penetration.

Contraindications

  • Pregnancy or breastfeeding (no safety data available)
  • Known allergy or hypersensitivity to any component amino acid in the peptide sequence
  • Active skin infections, open wounds, or severe dermatitis at application sites
  • History of contact dermatitis to cosmeceutical peptide products
  • Children under 18 (insufficient safety data)

Drug Interactions

  • Botulinum toxin (Botox, Dysport) — combined use may theoretically increase muscle relaxation effects; consult a dermatologist if using both
  • Topical retinoids (tretinoin, adapalene) — may increase skin sensitivity and irritation when layered; apply at separate times of day
  • Chemical exfoliants (AHAs, BHAs) — high-concentration peels may compromise the skin barrier and alter peptide absorption
  • Other neuromuscular-acting topical peptides (Argireline, Leuphasyl) — additive effects are possible; monitor for over-relaxation of facial muscles

Storage & Stability

Before Reconstitution
Store powder at -20°C for long-term stability, or 2-8°C for up to 6 months
After Reconstitution
Topical serums should be stored at 2-8°C away from light, use within 3 months after opening
Temperature
2-8°C (36-46°F) for prepared serums

Molecular Profile

Amino Acids
9
Sequence
EEEMQRRAD
HydrophobicPolarPositiveNegativeSpecialHow we generate these icons

Related Peptides

References

  1. Cosmeceutical Peptides in the Framework of Sustainable Wellness Economy (Molecules 2020)Review
  2. Acetyl Hexapeptide-8 in Cosmeceuticals — A Review of Skin Permeability and Efficacy (Int J Mol Sci 2025)Review
  3. A Synthetic Hexapeptide (Argireline) with Antiwrinkle Activity (Int J Cosmet Sci 2002)PubMed 18498523
  4. The Anti-Wrinkle Efficacy of Argireline in Chinese Subjects (Am J Clin Dermatol 2013)PubMed 23417317
  5. Pilot Study of Topical Acetyl Hexapeptide-8 in Treatment of Blepharospasm (J Neuroophthalmol 2013)PubMed 23146065

Frequently Asked Questions